Anupendra Sharma is the Global VP of Growth & Business Development at Siemens Healthineers within Enterprise Services & Solutions
Previously, he was Senior Investment Partner at Siemens Venture Capital. Anupendra served on the Board of USARAD, Seventh Sense, China Diagnostics (acquired by Actis & Orbimed), Sequenom (NASD: SQNM), BioImagene (acquired by Roche) and Cylex (acquired by Viracor-IBT), and served on the boards of Novira Therapeutics (Acquired by Johnson & Johnson) and Reflectance Medical (acquired by Zoll).
Prior to Siemens Venture Capital, Anupendra worked in M&A at JPMorgan, Salomon Smith Barney and Siemens. Anupendra also worked in strategy consulting for McKinsey, and Pro...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
